Pharmafile Logo
Pharmafocus logo
Advanced Search

China

Showing 15 posts of 258 posts found.

4420456374_64a3d7e6aa

Top Ten most popular articles on Pharmafile.com this week

February 22, 2019
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AstraZeneca, Cancer, China, MedImmune, Xeljanz, asthma, diabetes, keytruda, osteoarthritis, pharma, rare disease

Happy Friday! With the weekend within reach, check out our run-down of the top ten most popular articles on Pharmafile.com …

News
chinese_flag_beijing_-_img_1104

China to establish national rare disease network

February 19, 2019
Manufacturing and Production China, NHC, healthcare, rare diseases

China is set to establish a national collaborative network of hospitals for rare disease diagnosis and treatment to promote early …

News
amgen_flag

China’s NMPA approves Amgen’s Repatha to reduce cardiovascular event risk

January 25, 2019
Medical Communications, Sales and Marketing Amgen, China, Repatha, cardiovascular disease, pharma, stroke

Amgen has announced that its proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitor Repatha (evolocumab) has secured approval by China’s drug …

News
bi_german_building_at_night

Boehringer expands manufacturing facility in Shanghai

January 22, 2019
Manufacturing and Production Boehringer Ingelheim, China, Shanghai, facilities, manufacturing, pharma

German firm Boehringer Ingelheim has expanded the capacity of its commercial manufacturing site for biologics in Shanghai, China. The expansion …

News

Scientist who genetically modified babies faces punishment after acting illegally, Chinese authorities confirm

January 22, 2019
Manufacturing and Production China, He Jiankui, crispr, ethics, gene editing

Chinese state media have confirmed that He Jiankui, the scientist who claimed to have genetically modified babies to prevent them …

News
astrazeneca-sign

China becomes first country to approve roxadustat in chronic kidney disease

December 19, 2018
Research and Development, Sales and Marketing AstraZeneca, China, chronic kidney disease, pharma

AstraZeneca has announced that its partner Fibrogen has secured the first national approval for its hypoxia-inducible factor prolyl hydroxylase inhibitor …

News
tibet-3591529_960_720

Guangdong bans transportation of pigs due to African swine fever outbreak in Hunan

October 23, 2018
Research and Development ASF, African swine fever, China, Guangdong, Hunan, animal health

Chinese authorities have banned the transportation of live pigs from Guangdong to other regions, after reports of African swine fever …

News
novo_nordisk_flag

Novo Nordisk cuts 650 roles around the world in R&D restructure

October 1, 2018
Manufacturing and Production, Sales and Marketing China, Denmark, Novo Nordisk, UK, US, pharma

Novo Nordisk has announced a wave of jobs cuts as part of a global restructure of its $1 billion R&D …

News
novartis_window

Novartis strike $40m deal with Chinese firm Cellular Biomedicine

September 28, 2018
Medical Communications CAR T, CAR-T, China, Kymriah, Novartis, cellular biomedicine, prc

Swiss multinational Novartis have paired up with Chinese drugmaker Cellular Biomedicine (CBMG) in order to manufacture CAR-T therapy Kymriah in …

News
merckwindow_web

MSD to launch Keytruda at half US list price in China

September 20, 2018
Business Services, Sales and Marketing BMS, China, MSD, global, keytruda, markets, pricing

US pharma giant MSD will offer cutting edge cancer treatment Keytruda to Chinese patients at half the price at what …

News
astrazeneca_plaque

AstraZeneca to increase presence in China

September 19, 2018
Research and Development AstraZeneca, China, alibaba, governemnt, tencent

The Anglo-Swedish multinational AstraZeneca is moving towards becoming a major healthcare provider in China as part of an effort to …

News

Further six officials fired from China FDA

August 21, 2018
Manufacturing and Production CFDA, Changsheng biotechnology, China, Vaccine, scandal

A further six senior officials from the China Food and Drug Administration (CFDA) have been fired in relation to the …

News

Thyroid medication recalled after Chinese supplier fails inspection

August 20, 2018
Sales and Marketing China, FDA, recall, thyroid, westminster

The Mississippi based manufacturer Westminster Pharmaceuticals is voluntarily recalling thyroid medications Levothyroxine and Liothyronine after the Chinese company Sichuan Friendly …

News

Chinese regulators approve Roche’s Alecensa in regulatory shift

August 20, 2018
Sales and Marketing Cancer, China, Roche, approval, lung cancer

China’s National Drug Administration has granted rapid approval for Roche’s lung cancer treatment Alecensa (alectinib). Chinese regulators have in the …

News

CCP fire provincial official and investigate drug regulator in response to Changsheng vaccine scandal

August 17, 2018
Medical Communications China, Vaccine, changsheng, drug safety, regulation

The Chinese government has fired a senior provincial official and is probing a former senior drug regulator in response to …

News
The Gateway to Local Adoption Series

Latest content

Historic UN declaration supporting mental health – treatment to be given similar priority to chronic diseases

January 30, 2026

Rare diseases – spinal muscular atrophy

January 30, 2026

Could targeting the molecular causes of infertility finally transform IVF success rates?

January 29, 2026

Digital mental health technologies – a valuable tool in supporting people with depression and anxiety

January 29, 2026

Barts Health NHS Trust collaborates with H.I.G. Realty on healthcare innovation building

January 29, 2026